Mega Genomics Board to Review Annual Results and Final Dividend
I'm PortAI, I can summarize articles.
Mega Genomics Limited's board will meet on January 30, 2026, to review the annual results for the year ending December 31, 2024, and discuss the final dividend recommendation and other business matters. This announcement was published via the Issuer Information Service of the Hong Kong Stock Exchange.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments